[1]WHO. Global tuberculosis control: surveillance, planning, financing[M]. Geneva: World Health Organization, 2006.1-2. [2]Lozes E, Huygen K, Content J, et al. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex [J]. Vaccine,1997, 8(15):830-833. [3]Nagai S, Wiker HG, Harboe M, et al. Isolated and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis [J]. Infec Immun, 1991, 59(1):372-382. [4]Yuan Y, Crane DD, Simpson RM, et al. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages[J]. Proc Natl Acad Sci USA, 1998, 95(16):9578-9583. [5]Hu Y, Movahedzadeh F, Stoker NG, et al. Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo[J]. Infec Immun, 2006, 74(2):861-868. [6]Sartain MJ, Slayden RA, Singh KK, et al. Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling[J]. Mol Cell Proteomics, 2006, 5(11):2102-2113. [7]Davidow A, Kanaujia GV, Shi L, et al. Antibody profiles characteristic of Mycobacterium tuberculosis infection state[J]. Infec Immun,2005, 73(10):6846-6851. [8]Demissie A, Leyten EM, Abebe M, et al. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis[J]. Clin Vaccine Immunol, 2006, 13(2):179-186. [9]Britton WJ, Palendira U. Improving vaccines against tuberculosis[J]. Immunol Cell Biol, 2003, 81(1):34-45. [10]Louise R, Skjot V, Agger EM, et al. Antigen discovery and tuberculosis vaccine development in the post-genomic era[J]. Scand J Infect Dis, 2001, 33(9):643-647. [11]Chu RS, Targoni OS, Harding CV. CpG oligodeoxynucleotides act as adjuvant that switch on TH1 immunity[J]. J Exp Med,1997, 186(10):1623-1631. [12]Ivory CPA, Chadee K. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against entamoeba histolytica challenge[J]. Infect Immun,2007, 75(10):4917-4922.
|